Medtronic rises as recall shrugged off

NEW YORK
Shares of medical device maker Medtronic Inc. rose Tuesday after Wall Street shrugged off a 2 percent dip in the company's second-quarter profit on the recall of Sprint Fidelis heart wires.
The stock rose $3.17, or 7 percent, to $48.42 Tuesday. Shares have traded between $44.87 and $57.99 over the past 52 weeks.
Medtronic recalled the leads, which are wires that connect implantable defibrillators to the heart, in October, after discovering they broke more often than expected and contributed to at least five deaths. The stock reached an annual low Monday before rising.
Analysts said the impact from the recall was not as severe as initially forecast and that the worst of the impact is likely behind the company.

read the full article: http://www.businessweek.com/ap/financialnews/D8T1NR6O0.htm